CVE-2022-38351: Supremainc Biostar 2

High severity, CVSS 8.8. EPSS: 1.1% chance of exploitation in the next 30 days.

A vulnerability in Suprema BioStar (aka Bio Star) 2 v2.8.16 allows attackers to escalate privileges to System Administrator via a crafted PUT request to the update profile page.

Affected products

• Supremainc Biostar 2: version 2.8.16 only

Published 2022-09-19. Last modified 2026-06-17.